Ignite Creation Date:
2025-12-24 @ 3:16 PM
Ignite Modification Date:
2025-12-25 @ 9:25 PM
Study NCT ID:
NCT00055692
Status:
COMPLETED
Last Update Posted:
2016-02-29
First Post:
2003-03-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-02
Start Date Type:
None
Primary Completion Date:
2008-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-12
Completion Date Type:
ACTUAL
First Submit Date:
2003-03-06
First Submit QC Date:
None
Study First Post Date:
2003-03-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-08-25
Results First Submit QC Date:
None
Results First Post Date:
2016-02-29
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-01-29
Last Update Post Date:
2016-02-29
Last Update Post Date Type:
ESTIMATED